The United Arab Emirates (UAE) has officially registered the inactivated COVID-19 vaccine developed by Sinopac, according to a statement released by the Uae's Ministry of Health and Prevention on Dec. 9, the Wall Street Journal reported.This is a major vote of confidence by the Uae government in the safety and efficacy of the vaccine.

The statement said the Ⅲ phase of clinical trial show that the inactivated vaccine against will be coronavirus infection of the effective rate was 86%.The vaccine has a 99 per cent neutralising antibody serum conversion rate and is 100 per cent effective in preventing mild COVID-19 from converting to moderate and severe disease.In addition, the analysis showed that the vaccine posed no serious safety risks.